Article
CB-5083 and luteolin synergistically induce apoptosis of bladder cancer cells via multiple mechanisms
2023-08-23
Abstract excerpt
<h4>Purpose: </h4> Bladder cancer (BC) is a common urological malignancy that still lacks of effective treatments. In recent years, valosin-containing protein (VCP) was emerging as potential target for the treatment of cancers. CB-5083 was a VCP inhibitor that has been evaluated in phase I clinical trials. However, drug-resistance and severe side effects hamper the application of CB-5083. Amounting evidence sugges...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6c695433-23d2-5c43-98b3-21d906b924ae
- DOI
- 10.21203/rs.3.rs-3270847/v1
